Spring Co-op/Target Validation
GSK
Summary
An opportunity has arisen for a highly motivated graduate student to join the Target Validation department within Target Discovery at GSK's facility in Upper Providence, Pennsylvania. The department conducts target validation studies to build confidence in drug targets and deliver robust data packages that support early drug discovery across GSK's therapeutic modalities, including small molecules, biologics, and oligonucleotides. The department uses genetic and pharmacological perturbation studies to advance the mechanistic understanding of drug targets.
Job description
Department Description
An opportunity has arisen for a highly motivated graduate student to join the Target Validation department within Target Discovery at GSK's facility in Upper Providence, Pennsylvania. The department conducts target validation studies to build confidence in drug targets and deliver robust data packages that support early drug discovery across GSK's therapeutic modalities, including small molecules, biologics, and oligonucleotides. The department uses genetic and pharmacological perturbation studies to advance the mechanistic understanding of drug targets.
Job Description
This position will receive guidance and mentoring from experienced professionals in Target Validation. The candidate will generate cellular reagents and conduct target validation studies to support programs in multiple therapeutic areas. In this role, the candidate will gain hands-on experience in CRISPR-mediated genome editing, next-generation sequencing, and Oxford Nanopore Technologies. It also offers networking opportunities to connect with professionals across different functional units within the pharmaceutical industry.
Minimum Qualifications
- Must be currently pursuing a Master or Ph.D. in Biology (Molecular Biology, Cell Biology, Genetics, Oncology, etc.), Biochemistry, Biotechnology, Biomedical engineering or similar.
- Experience in mammalian cell culture.
- Must be able to work full-time (35-40 hours/week) throughout the 6-month co-op (March 2027 ~ September 2027).
- Must have an active student status and/or within 12 months post-graduation from a BS or MS degree program. Post-doctoral candidates are not eligible.
Preferred Qualifications
- Familiar with basic molecular biology techniques such as DNA isolation, molecular cloning, PCR etc.
- Basic knowledge about genome editing (CRISPR) and sequencing technologies.
- Attention to detail. Excellent documentation, organization, data analysis and communication skills.
- Enthusiasm and excitement for cutting-edge genome editing and sequencing technologies.
Requirements
- Currently pursuing a Master or Ph.D. in Biology (Molecular Biology, Cell Biology, Genetics, Oncology, etc.), Biochemistry, Biotechnology, Biomedical engineering or similar
- Experience in mammalian cell culture
- Must be able to work full-time (35-40 hours/week) throughout the 6-month co-op (March 2027 ~ September 2027)
- Must have an active student status and/or within 12 months post-graduation from a BS or MS degree program
- Post-doctoral candidates are not eligible
- Must successfully pass a drug screen and background check prior to assignment target start date
- Familiar with basic molecular biology techniques such as DNA isolation, molecular cloning, PCR etc.
- Basic knowledge about genome editing (CRISPR) and sequencing technologies
- Attention to detail
- Excellent documentation, organization, data analysis and communication skills
- Enthusiasm and excitement for cutting-edge genome editing and sequencing technologies
Benefits
- Relocation stipend
- Competitive hourly pay
- Medical benefits
- Fringe benefits
- Overtime pay
Company overview
GSK plc (formerly GlaxoSmithKline) is a British multinational pharmaceutical and biotechnology company headquartered in London, England. Founded in 2000 through the merger of Glaxo Wellcome and SmithKline Beecham, GSK has grown to become one of the world's leading healthcare companies with operations in over 150 countries. The company specializes in researching, developing, and manufacturing prescription medicines, vaccines, and consumer healthcare products. GSK's therapeutic areas include respiratory diseases, HIV/AIDS, oncology, immunology, and infectious diseases. The company is particularly renowned for its vaccine portfolio and has been at the forefront of developing treatments for major global health challenges. With approximately 70,000 employees worldwide, GSK maintains a strong commitment to scientific innovation and has a significant presence in key markets including the United States, Europe, and emerging economies. The company's mission is to unite science, technology, and talent to get ahead of disease together, aiming to positively impact the health of 2.5 billion people by the end of the decade.